These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9858967)

  • 21. Are dual-coil ICD leads obsolete?
    Barold SS; Herweg B
    Pacing Clin Electrophysiol; 2013 Aug; 36(8):923-5. PubMed ID: 23844902
    [No Abstract]   [Full Text] [Related]  

  • 22. Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer.
    Landolina M; Curnis A; Morani G; Vado A; Ammendola E; D'onofrio A; Stabile G; Crosato M; Petracci B; Ceriotti C; Bontempi L; Morosato M; Ballari GP; Gasparini M
    Europace; 2015 Aug; 17(8):1251-8. PubMed ID: 25976906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New transvenous implantable cardioverter defibrillator configuration for use after tricuspid valve surgery.
    Lopez JA
    Europace; 2008 Jun; 10(6):736-7. PubMed ID: 18424456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of postoperative testing of implantable cardioverter-defibrillators.
    Sauer WH; Lowery CM; Bargas RL; Schuller JL; Stees CS; Aleong RG; Varosy PD
    Pacing Clin Electrophysiol; 2011 Feb; 34(2):186-92. PubMed ID: 21039640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Factors predisposing to the reprogramming of implantable cardioverter-defibrillators and the causes of changes in pharmacotherapy in patients with dilated cardiomyopathy for primary prevention of sudden cardiac death].
    Pudło J; Liszniański P; Senderek T; Lelakowska-Pieła M; Lelakowski J; Nowak J
    Pol Merkur Lekarski; 2015 Aug; 39(230):86-90. PubMed ID: 26319381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Automated implantable cardioverter/defibrillators. Indications for implantation and clinical results].
    Ulbricht LJ; Emmerich K; Probst H; Krakau I; Gülker H
    Z Kardiol; 1995; 84 Suppl 2():127-36. PubMed ID: 7571776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Permanent pacemakers and implantable defibrillators: considerations for intensivists.
    McPherson CA; Manthous C
    Am J Respir Crit Care Med; 2004 Nov; 170(9):933-40. PubMed ID: 15297272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The cardiac pacemaker beeps faithfully every day].
    Sattler R
    MMW Fortschr Med; 2015 Mar; 157(5):10. PubMed ID: 26014986
    [No Abstract]   [Full Text] [Related]  

  • 29. When life-saving devices terminate life.
    Catanchin A; Anderson L; Jones S; Ward D
    J Cardiovasc Electrophysiol; 2008 Mar; 19(3):316-8. PubMed ID: 18266677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefits of implantable cardiac defibrillators in heart failure are confirmed.
    Tanne JH
    BMJ; 2004 Mar; 328(7441):664. PubMed ID: 15031233
    [No Abstract]   [Full Text] [Related]  

  • 31. Data analysis and interpretation of results in DATAS trial.
    Vardanyan Z; Kanna B
    Europace; 2008 Oct; 10(10):1243; author reply 1243-4. PubMed ID: 18796503
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiple high lead impedances in an implantable-cardioverter defibrillator system: what is the mechanism?
    Ho RT
    Pacing Clin Electrophysiol; 2013 Sep; 36(9):1173-5. PubMed ID: 23594162
    [No Abstract]   [Full Text] [Related]  

  • 33. Failure of an implantable cardioverter defibrillator to terminate ventricular tachycardia: why?
    Conti L; Tran N; Burri H; Zimmermann M
    Pacing Clin Electrophysiol; 2010 Feb; 33(2):228-30. PubMed ID: 19821932
    [No Abstract]   [Full Text] [Related]  

  • 34. Defibrillation testing in everyday medical practice during implantable cardioverter defibrillator implantation in France: analysis from the LEADER registry.
    Sadoul N; Defaye P; Mouton E; Bizeau O; Dupuis JM; Blangy H; Delarche N; Blanc JJ; Lazarus A;
    Arch Cardiovasc Dis; 2013 Nov; 106(11):562-9. PubMed ID: 24200925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of electromagnetic interference on implanted cardiac devices and their management.
    Yerra L; Reddy PC
    Cardiol Rev; 2007; 15(6):304-9. PubMed ID: 18090066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tune-ups. Implantable cardiac device manufacturers are looking for better ways to monitor their products' functionality. But is it making a difference?
    Mettner J
    Minn Med; 2006 Nov; 89(11):12-3. PubMed ID: 17153893
    [No Abstract]   [Full Text] [Related]  

  • 37. [Interview with S. Lévy. Apropos of recommendations on defibrillators. Interview by M. Hérida].
    Lévy S
    Presse Med; 1998 Nov; 27(37):1907-8. PubMed ID: 9858968
    [No Abstract]   [Full Text] [Related]  

  • 38. Atrial fibrillation in patients with implantable defibrillators.
    Sakhuja R; Shah AJ; Keebler M; Thakur RK
    Cardiol Clin; 2009 Feb; 27(1):151-61, ix-x. PubMed ID: 19111771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety of implantable pacemakers and cardioverter defibrillators in the magnetic field of a novel remote magnetic navigation system.
    Jilek C; Tzeis S; Reents T; Estner HL; Fichtner S; Ammar S; Wu J; Hessling G; Deisenhofer I; Kolb C
    J Cardiovasc Electrophysiol; 2010 Oct; 21(10):1136-41. PubMed ID: 20522155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case report of out-of-hospital heat dissipation of an implantable cardioverter-defibrillator.
    Hudec M; Kaliska G
    Europace; 2011 Jun; 13(6):902-4. PubMed ID: 20876600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.